Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
14 Apr 2022
// A. Liu FIERCEPHARMA
https://www.fiercepharma.com/drug-delivery/jj-roche-partner-halozyme-buys-antares-pharma-1b-beefing-drug-delivery-offerings
29 Mar 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/03/29/2411744/35385/en/Antares-Pharma-Announces-FDA-Approval-Of-TLANDO-an-Oral-Treatment-for-Testosterone-Replacement-Therapy.html
03 Mar 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/03/03/2396099/35385/en/Antares-Pharma-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-and-Operating-Results.html
28 Feb 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/02/28/2393191/35385/en/Antares-Pharma-to-Present-at-the-Cowen-42nd-Annual-Healthcare-Conference.html
03 Feb 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/02/03/2378482/35385/en/Antares-Pharma-Announces-FDA-Acceptance-of-NDA-Resubmission-for-TLANDO.html
03 Feb 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/lipocine-announces-its-partner-received-fda-acceptance-of-nda-resubmission-for-tlando-301474456.html
Inspections and registrations
ABOUT THIS PAGE